11079 related articles for article (PubMed ID: 1080748)
1. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.
Hersey P; Edwards J; Edwards A; Adams E; Kearney R; Milton GW
Int J Cancer; 1975 Jul; 16(1):164-72. PubMed ID: 1080748
[TBL] [Abstract][Full Text] [Related]
2. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells.
Hersey P; Edwards A; Edwards J; Adams E; Milton GW; Nelson DS
Int J Cancer; 1975 Jul; 16(1):173-83. PubMed ID: 51832
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
5. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
6. In vitro assay of spontaneous cytotoxicity by human monocytes and macrophages against tumor cells.
Mukherji B
J Immunol Methods; 1980; 37(3-4):233-47. PubMed ID: 7451996
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
8. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
9. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
Steele G; Sjögren HO; Lannerstad O; Stadenberg I
Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
Zöller M; Price MR; Baldwin RW
Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
Saal JG; Rieber EP; Riethmüller G
Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
[TBL] [Abstract][Full Text] [Related]
14. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mononuclear effector cells in human blood.
Hersey P; Edwards A; Edwards J
Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
Saal JG; Rieber EP; Hadam M; Riethmuller G
Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
[No Abstract] [Full Text] [Related]
17. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients.
de Vries JE; Mendelsohn J; Bont WS
Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB
J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761
[TBL] [Abstract][Full Text] [Related]
19. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
de Vries JE; Cornain S; Rumke P
Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
[No Abstract] [Full Text] [Related]
[Next] [New Search]
